文献
J-GLOBAL ID:201902251090513076
整理番号:19A2906172
未治療,EGFR変異,進行性非小細胞肺癌(リレー)患者におけるラムコリマブ+エルロチニブ:無作為化二重盲検プラセボ対照第3相試験【JST・京大機械翻訳】
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
著者 (20件):
Nakagawa Kazuhiko
(Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan)
,
Garon Edward B
(David Geffen School of Medicine at University of California Los Angeles, Translational Research in Oncology US Network, Los Angeles, CA, USA)
,
Seto Takashi
(National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan)
,
Nishio Makoto
(Department of Thoracic Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Ponce Aix Santiago
(Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense and Ciberonc, Madrid, Spain)
,
Paz-Ares Luis
(Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense and Ciberonc, Madrid, Spain)
,
Chiu Chao-Hua
(Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan)
,
Park Keunchil
(Samsung Medical Center, Division of Hematology and Oncology, Sungkyunkwan University School of Medicine, Seoul, South Korea)
,
Novello Silvia
(Department of Oncology, University of Turin, Azienda ospedaliero-universitaria San Luigi, Orbassano, Italy)
,
Nadal Ernest
(Department of Medical Oncology, Catalan Institute of Oncology, and Clinical Research in Solid Tumors group, Oncobell, l’Institut d’Investigacio Biomedica de Bellvitge, L’Hospitalet, Barcelona, Spain)
,
Imamura Fumio
(Osaka International Cancer Institute, Osaka, Japan)
,
Yoh Kiyotaka
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Shih Jin-Yuan
(Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan)
,
Au Kwok Hung
(Queen Elizabeth Hospital, Kowloon, Hong Kong)
,
Moro-Sibilot Denis
(Grenoble University Hospital, Grenoble, France)
,
Enatsu Sotaro
(Eli Lilly Japan KK Kobe, Kobe, Japan)
,
Zimmermann Annamaria
(Eli Lilly and Company, Indianapolis, IN, USA)
,
Frimodt-Moller Bente
(Eli Lilly and Company, Copenhagen, Denmark)
,
Visseren-Grul Carla
(Lilly Oncology, Utrecht, Netherlands)
,
Reck Martin
(LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
20
号:
12
ページ:
1655-1669
発行年:
2019年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)